1. Home
  2. AAPG vs TFIN Comparison

AAPG vs TFIN Comparison

Compare AAPG & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • TFIN
  • Stock Information
  • Founded
  • AAPG 2009
  • TFIN 1981
  • Country
  • AAPG China
  • TFIN United States
  • Employees
  • AAPG N/A
  • TFIN N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • TFIN Major Banks
  • Sector
  • AAPG Health Care
  • TFIN Finance
  • Exchange
  • AAPG Nasdaq
  • TFIN Nasdaq
  • Market Cap
  • AAPG 1.7B
  • TFIN 1.5B
  • IPO Year
  • AAPG 2025
  • TFIN N/A
  • Fundamental
  • Price
  • AAPG $23.04
  • TFIN $57.51
  • Analyst Decision
  • AAPG Buy
  • TFIN Hold
  • Analyst Count
  • AAPG 1
  • TFIN 6
  • Target Price
  • AAPG N/A
  • TFIN $77.50
  • AVG Volume (30 Days)
  • AAPG 26.1K
  • TFIN 198.8K
  • Earning Date
  • AAPG 03-27-2025
  • TFIN 04-16-2025
  • Dividend Yield
  • AAPG N/A
  • TFIN N/A
  • EPS Growth
  • AAPG N/A
  • TFIN N/A
  • EPS
  • AAPG N/A
  • TFIN 0.54
  • Revenue
  • AAPG $134,352,180.00
  • TFIN $396,285,000.00
  • Revenue This Year
  • AAPG $328.14
  • TFIN $17.60
  • Revenue Next Year
  • AAPG N/A
  • TFIN $12.72
  • P/E Ratio
  • AAPG N/A
  • TFIN $105.52
  • Revenue Growth
  • AAPG 341.77
  • TFIN N/A
  • 52 Week Low
  • AAPG $16.50
  • TFIN $56.50
  • 52 Week High
  • AAPG $23.37
  • TFIN $110.58
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • TFIN 29.36
  • Support Level
  • AAPG N/A
  • TFIN $60.76
  • Resistance Level
  • AAPG N/A
  • TFIN $65.64
  • Average True Range (ATR)
  • AAPG 0.00
  • TFIN 2.76
  • MACD
  • AAPG 0.00
  • TFIN 0.19
  • Stochastic Oscillator
  • AAPG 0.00
  • TFIN 11.05

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks: